[IN] HEA MTC MEQ
-- WITH PHOTO -- TO BUSINESS, HEALTH, AND MEDICAL EDITORS:
67% of U.S. SynCardia Certified Centers Make Becker's 100 Great
American Hospitals List
TUCSON, Ariz., April 8, 2014 /PRNewswire/ -- More than two-thirds, 35,
of SynCardia's 52 Certified Centers in the United States are on the
"100 Great Hospitals in America" list published by Becker'sHospital
"When more than a third of America's top 100 hospitals have the
SynCardia temporary Total Artificial Heart it clearly demonstrates
that our device is rapidly becoming the standard of care for end-stage
biventricular heart failure," says Michael P. Garippa, SynCardia
Systems, Inc. CEO and President.
SynCardia Certified Centers use the SynCardia Total Artificial Heart
to save patients dying from end-stage biventricular (both sides) heart
failure and bridge them to a donor heart transplant. It is the world's
first and only FDA, Health Canada and CE approved Total Artificial
Like a heart transplant, the SynCardia Total Artificial Heart replaces
the two failing heart ventricles and four valves. It is the only
approved device in the world that eliminates the source and symptoms
of end-stage biventricular heart failure.
Becker's Hospital Review cited the cardiology and cardiac surgery
services at many of these SynCardia hospitals as reasons they were
included in the list. The editorial staff of the publication for
high-level hospital leaders compiled the list from research efforts,
nominations and evaluations of hospital ranking sources such as U.S.
News & World Report, Truven Health Analytics and Healthgrades.
There are 97 SynCardia Certified Centers worldwide with an additional
39 hospitals in the process of completing the four-phase certification
program. Nearly 1,300 SynCardia Heart implants have been performed
worldwide, including 400 since 2011.
>> Read what Becker's Hospital Review says about its "100 Great
Hospitals in America."
CAUTION - The Freedom portable driver is an investigational device,
limited by United States law to investigational use.
About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held
manufacturer of the world's first and only FDA, Health Canada and CE
approved Total Artificial Heart. Originally used as a permanent
replacement heart, the SynCardia Total Artificial Heart is currently
approved as a bridge to transplant for people suffering from end stage
heart failure affecting both sides of the heart (biventricular
failure). There have been more than 1,260 implants of the Total
Artificial Heart, accounting for more than 350 patient years of life
on the device.
Similar to a heart transplant, the SynCardia Total Artificial Heart
replaces both failing heart ventricles and the four heart valves. It
is the only device that eliminates the symptoms and source of end
stage biventricular failure. Unlike a donor heart, the Total
Artificial Heart is immediately available at 97 SynCardia Certified
Centers worldwide with 39 others in the process of certification.
The Total Artificial Heart provides immediate, safe blood flow of up
to 9.5 liters per minute through each ventricle. This high volume of
blood flow helps speed the recovery of vital organs, helping make the
patient a better transplant candidate.
For additional information, please visit: http://www.syncardia.com/
Like SynCardia on Facebook Follow SynCardia on Twitter - @SynCardia
Connect with SynCardia on LinkedIn
SOURCE SynCardia Systems, Inc.
/CONTACT: Don Isaacs, Vice President of Communications, SynCardia Systems, Inc., Cell: (520) 955-0660, firstname.lastname@example.org
PRN Photo Desk, email@example.com
/Web Site: http://www.syncardia.com
CO: SynCardia Systems, Inc.; Beckers Hospital Review
IN: HEA MTC MEQ
-- LA00151 --
0000 04/08/2014 14:00:00 EDT http://www.prnewswire.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.